Reaction profile

The FDA adverse-event record for anuria

423 FDA reports name anuria, a high-volume reaction in the CVM extract (VeDDRA 712). Plate stamps and neighbourhood peers follow.

#704 of 2,481
by report volume (all reactions)
423
reports citing this reaction
45.6%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Anuria has 423 reports now versus 418 in that prior snapshot: 5 more (1.2%).

Report change
+5
Death-coded reports
+3
Death-coded share
+0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Anuria changes

FDA AER · VeDDRA plate

Code 712 VOL-LOW

VOL-LOW · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-LOW 423 reports
  • DEATH-HOT 45.6%
  • MID-PACK #704/2481
  • PHOTO-FINISH Decreased percentage…
  • SPECIES-DOG Dog · 234
  • DRUG-LEAD Buprenorphine · 52
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Decreased percentage of reticulocytes (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

High-volume neighbourhood around Anuria

Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Lip oedema (see also… · near425Decreased heart rate · near424Anuria · this reaction423Decreased percentage… · near423Respiratory tract inf… · near422Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Anuria

Anuria: high death-coded share in the FDA AER plate

Signature read: 193 death-coded reports is a heavy tail count for Anuria in the CVM extract. Report volume is upper-third scale: 423 named reports in the openFDA extract. Death-coded share is upper-third: 193 of 423 reports (45.6% of named reports). Nearest volume peer: Decreased percentage of reticulocytes (±0 reports). Lead species Dog (234). Lead co-reported drug Buprenorphine (52).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 234
Cat 182
Horse 5
Guinea Pig 1
Other 1

Breeds Most Affected

Domestic Shorthair 82
Domestic (unspecified) 27
Retriever - Labrador 21
Cat (unknown) 17
Chihuahua 16
Retriever - Golden 15
Domestic Longhair 14
Crossbred Canine/dog 12
Terrier - Yorkshire 12
Shih Tzu 11

Associated Drugs

Buprenorphine 52
Meloxicam 49
Maropitant Citrate 47
Carprofen 44
Robenacoxib 38
Isoflurane 28
Milbemycin Oxime + Spinosad 25
Selamectin 19
Dexmedetomidine 18
Cefovecin 17
Gabapentin 17
Propofol 15
Deracoxib 14
Imidacloprid + Moxidectin 14
Cefovecin Sodium 13
Spinosad 12
Tramadol 11
Midazolam 11
Fluid Therapy 11
Bedinvetmab 11

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Anuria, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar death-coded share

Nearest other reactions by death-coded share (45.6% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Anuria (#704 of 2,481 by report volume); death-coded 45.6%. PlainBreed reaction plate · death-coded report count stamp 193 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →